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Abstract Flavanone 3L-hydroxylase (FHT), a 2-oxoglutarate-
dependent dioxygenase (2-ODD), catalyzes the hydroxylation of
(2S)-£avanones to (2R/3R)-dihydro£avonols in plants as a key
step towards the biosynthesis of £avonols, anthocyanins and
catechins. Crystallographic studies of 2-ODDs typically re-
vealed a jelly roll in the enzyme core, and the C-terminus of
the enzyme polypeptides was proposed to form a lid covering the
active site cavity, thereby reducing the chances for oxidative or
proteolytic damage and unfolding. Moreover, it has been pro-
posed that in some cases the C-terminus is involved in substrate
selectivity of 2-ODDs. In a systematic approach with highly
active Petunia FHT, four C-terminally truncated enzyme forms
were generated by deletion of ¢ve, 11, 24 or 29 amino acids. The
recombinant FHTs preserved their substrate selectivity, but the
speci¢c activity decreased gradually with the extent of trunca-
tion. Then, an enzyme chimera was constructed by domain
swapping replacing the C-terminal 52 amino acids of Petunia
FHT by the equivalent region of £avonol synthase (FLS) from
Citrus unshiu, an enzyme showing ambiguous FLS and FHT
activity. The chimeric dioxygenase still revealed exclusively
FHT activity, albeit at a moderate level only. The data predict
that the selectivity of FHT is not governed by the C-terminal
sequence accounting for about 13% of the enzyme polypeptide.
5 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Key words: Flavonoid biosynthesis; Flavanone
3L-hydroxylase; Flavonol synthase; C-terminal mutation;
Selectivity; Petunia hybrida ; Citrus unshiu
1. Introduction
Flavonoids form a large group of secondary metabolites
that serve important physiological functions during plant
growth and development, but have received also attention
for their pharmacological traits [1]. Investigations of the bio-
synthesis of £avonoids identi¢ed four 2-oxoglutarate-depen-
dent dioxygenases (2-ODDs) catalyzing hydroxylation or de-
saturation reactions, which include £avanone 3L-hydroxylase
(FHT) [2], £avone synthase I (FNS I) [3], £avonol synthase
(FLS) [4] and anthocyanidin synthase (ANS) [5]. FHT activity
converting (2S)-£avanones to (2R,3R)-dihydro£avonols (Fig.
1) was described initially from crude extracts of Matthiola
incana [6] and illuminated parsley cell cultures [7]. The enzyme
was cloned subsequently from Petunia hybrida [8] and func-
tionally expressed as a highly active recombinant enzyme in
Escherichia coli. Genuine FHT consists of a 41 655 Da poly-
peptide which, unfortunately, is prone to rapid proteolysis in
crude plant extracts as well as in the extracts from recombi-
nant expression in bacteria [8,9]. Upon proteolysis, predom-
inantly a carboxy-terminal portion of about 3.8 kDa was re-
moved followed by further truncations and concomitant with
severe losses in enzyme activity [10]. The 3.8 kDa C-terminal
portion appeared to be essential for Petunia FHT activity, and
this might be due in part to a small far downstream sequence
motif which is conserved in FHTs from widely di¡erent plants
[11].
Soluble dioxygenases depend on FeII for catalysis and re-
quire a coreductant, which is often, but not always, 2-oxoglu-
tarate. The in vitro activity of 2-ODDs is often stimulated by
reducing agents such as ascorbate, which probably act in part
by stabilizing the Fe2þ redox state of the enzyme cofactor. A
number of conserved sequence motifs have been identi¢ed in
true 2-ODDs and related oxygenases and oxidases, such as
isopenicillin N synthase (IPNS), although the overall extent
of homology may be low. These enzymes which take part in a
broad spectrum of primary and secondary biosynthetic path-
ways in animals, plants and microorganism are often accred-
ited with an environmental, pharmaceutical or medical impact
[12^14] and have therefore been thoroughly studied. The crys-
tallization and X-ray di¡raction of 2-ODDs which include
deacetoxycephalosporin C synthase (DAOCS) [15], clavaminic
acid synthase (CAS) [16], carbapenem synthase (CarC) [17],
proline 3-hydroxylase (P3H) [18], ANS [19], taurine/K-keto-
glutarate dioxygenase [20] and the factor-inhibiting hypoxia-
inducible factor [21] as well as of the related IPNS [22] have
been accomplished. Irrespective of their sequence di¡erences,
these enzyme polypeptides adopt a very similar spatial con¢g-
uration, in particular considering the active sites which are
embedded in a double-stranded L-helix topology [23]. Further-
more, a lid function was assigned to the C-terminal portion
which, in concert with conformational changes, was assumed
to shield the substrate during catalysis and may assist in the
coordination of the active site ligands [24]. Accordingly, re-
moval of six amino acids from the C-terminus of Aspergillus
nidulans IPNS [25] or Streptomyces clavuligerus DAOCS
[15] led to considerable losses in catalytic activity, whereas
deletion of 20 amino acids from the C-terminus of Acremo-
nium chrysogenum DAOCS/deacetylcephalosporin C synthase
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(DACS) did not a¡ect penicillin ring expansion [26]. However,
experiments with chimeric gibberellin C-20 oxidases clearly
emphasized that the C-terminus plays an essential role for
product selectivity [27]. Thus, the functional signi¢cance of
the C-terminal portion must be examined individually for
each 2-ODD, and the composition of conserved and variable
elements in this polypeptide region might be the cause of
subtle di¡erences.
In order to decipher the relevance of conserved and variable
C-terminal regions, mutation studies were done on recombi-
nant Petunia FHT which had been expressed and puri¢ed in a
highly active state [10]. Four C-terminal deletions of various
length were introduced, and an FHT chimera was generated
by replacing the Petunia FHT C-terminus with the corre-
sponding sequence from Citrus FLS.
2. Materials and methods
2.1. Materials
Biochemicals of analytic grade were purchased from Amersham-
Pharmacia (Freiburg, Germany), Serva (Heidelberg, Germany), Sigma
(Deisenhofen, Germany), Roche Diagnostics (Mannheim, Germany)
or Roth (Karlsruhe, Germany). Reference samples of (2S)-[4a,6,8-
14C]naringenin were collected from preparative incubations of
[2-14C]malonyl-coenzyme A (CoA) and 4-coumaroyl-CoA as de-
scribed previously [9], employing recombinant chalcone synthase
from Pinus sylvestris [28] and partially puri¢ed chalcone isomerase
from parsley [29]. (2S)-[4a,6,8-14C]dihydrokaempferol was prepared
from (2S)-[4a,6,8-14C]naringenin as described [10]. The purity of the
labeled £avonoids was routinely veri¢ed by thin-layer radiochroma-
tography, and the pure compounds were dissolved in ethyl acetate and
stored at 320‡C until use.
2.2. Mutagenesis and cDNA construction
Based on the FHT-pTZ19R plasmid [30] the FHT mutants CT1,
CT2, CT3 and CT4 were generated by site-directed mutagenesis fol-
lowing the procedure of Kunkel et al. [31] and using custom-synthe-
sized oligonucleotide primers (Table 1) (G. Igloi, Institut fu«r Biologie
III, Universita«t Freiburg). Similarly, oligonucleotide primers (FHT-
KpnI, FLS-KpnI, Table 1) were designed for the introduction of
KpnI restriction sites at homologous 3P regions of FHT and FLS
cDNAs, and site-directed mutagenesis was performed as described
[4,32]. The double-digested 5P-NcoI/KpnI-3P-FHT gene fragment was
isolated after puri¢cation on an 0.8% agarose gel by using the SpS
BIOTRAP elektro-separation system (SchleicherpSchuell, Dassel,
Germany). In order to obtain the cDNA fragment encoding the C-ter-
minal region of FLS the FLS-KpnI cDNA was spliced from the FLS-
pTZ19R plasmid with KpnI and XhoI. The 5P-KpnI/XhoI-3P-FLS con-
struct was isolated by agarose gel electrophoresis and assembled with
the 5P-NcoI/KpnI-3P-FHT fragment to a full-length chimeric 5P-FHT/
FLS-3P cDNA construct by ligation with the NcoI/XhoI double-di-
gested FLS-pTZ19R vector (Fig. 2). Subsequently, the KpnI restric-
tion site of the chimeric 5P-FHT/FLS-3P product was eliminated by
point mutation in a similar manner as described above (Fig. 2). Each
individual mutation was veri¢ed by dideoxy chain termination DNA
sequencing [33] using the universal and reverse sequencing primers.
The construction of expression vectors was performed with standard
techniques [34], the mutant FHT cDNAs (CT1^CT4) and the chimeric
5P-FHT/FLS-3P cDNA were spliced from pTZ19R vectors with NcoI
and PstI, and the inserts were subcloned into the expression vector
pQE6 or in case of the chimera in pQE60. E. coli M15 harboring the
plasmid pRep4 was transformed with the mutant FHT-pQE6 and the
chimeric 5P-FHT/FLS-3P-pQE60 construct, and the cells were propa-
gated, induced for expression and harvested as described previously
[10,32].
2.3. Enzyme expression and general assays
Crude extracts from bacteria expressing mutant FHT (CT1, CT2,
CT3, CT4) or the chimeric FHT/FLS polypeptide were prepared by
Fig. 1. FHT catalyzes the 3L-hydroxylation of (2S)-£avanones to (2R,3R)-dihydro£avonols, i.e. naringenin to dihydrokaempferol. The enzyme
from Petunia accepts also eriodictyol or pinocembrin as a substrate to yield taxifolin and pinobanksin, respectively.
Table 1
Oligonucleotides for site-directed mutagenesis
Enzyme mutant Oligonucleotidea Codon exchange
FHT-CT1 5P-GAATTTCCTAAATGGGC-3P GAGCTAG
FHT-CT2 5P-GGACTCCTACTTAGCC-3P TTGCTAG
FHT-CT3 5P-CTGCTGCTACTTGGCC-3P GAGCTAG
FHT-CT4 5P-CCTGCTTCTAGAGCCTAGC-3P AAGCTAG
FHT-KpnI 5P-CAAATGTTATGGTACCATCCATTATTG-3P GAGCGGT, CCCCACC
FLS-KpnI 5P-CCTTGAACTTCTTGGTACCGTACTTTGG-3P AAGCGGT, GCCCACC
FHT/FLS chimera 5P-CCTTGAACTTCTTGGCCTTATCCATTATTG-3P GGTCAAG, ACCCGCC
aOligonucleotides spanning the site of mutation (bold printed, base substitution underlined) in Petunia FHT or Citrus FLS were designed to in-
troduce stop codons (FHT-CT1^CT4) or KpnI restriction sites (FHT-KpnI and FLS-KpnI) and to reverse the KpnI restriction site (FHT/FLS
chimera).
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ultrasonication followed by centrifugation (30 000Ug, 4‡C, 10 min).
The clear supernatants of CT1^CT4 were precipitated with ammo-
nium sulfate (20^55% saturation), dissolved in potassium phosphate
bu¡er pH 5.5 (1 ml) and immediately subjected to size exclusion
chromatography on a Fractogel EMD BioSEC column (Merck
KgaA, Darmstadt, Germany) which had been equilibrated with
Tris^HCl bu¡er pH 7.5 [10]. Mutant FHTs were puri¢ed to homoge-
neity by subsequent anion exchange chromatography on Fractogel
EMD DEAE 650 (S) (Merck KgaA) in Tris^HCl bu¡er at pH 7.5.
The protein composition of samples was examined by sodium dodecyl
sulfate^polyacrylamide gel electrophoresis (SDS^PAGE) [35] and
Western blotting [36], and protein was quanti¢ed after trichloroacetic
acid precipitation according to Lowry [37] with bovine serum albumin
as a reference. The activities of FHTs and FLS were determined as
reported previously [4,32]. Labeled £avonoid products were extracted
from the incubations with 150 Wl ethyl acetate, separated by chroma-
tography on cellulose thin-layer plates (Merck KgaA) in 15% aqueous
acetic acid and compared quantitatively by bioimaging using a Fuji
Fig. 2. Schematic mapping of plasmids for the construction of an enzyme chimera from P. hybrida FHT and C. unshiu FLS. KpnI restriction
sites (bold printed) were introduced into FHT-pTZ19R (A) and FLS-pTZ19R (B) by site-directed mutagenesis, and the chimeric FHT plasmid
(C) was constructed by swapping of the C-terminal domain (downstream from the KpnI site) of the FLS to the N-terminal FHT domain. Sub-
sequently, the KpnI restriction site of the chimera was eliminated by point mutation (D). Only the relevant restriction sites are indicated below,
numbers on top refer to the amino acid residues, and sequence motifs generated at the KpnI restriction sites are assigned in the bottom line.
Fig. 3. Alignment of the C-terminal portions of six FHT polypeptides corresponding to the terminal 50 residues of petunia FHT. GenBank ac-
cession numbers of sequences are listed in the left margin (Pet, P. hybrida ; Chr, Chrysanthemum morifolium ; Cit-s, Citrus sinensis ; Vit, Vitis
vinifera ; All, Allium cepa ; Zea, Zea mays). Numbers in the right margin refer to the C-terminal amino acid of the individual sequence, and ar-
rows mark the C-terminal end of Petunia FHT mutants (CT1^CT4) or of the proteolytic Petunia FHT fragment (CT5) isolated from crude ex-
tracts [10]. The sequence elements spanning the residues 320^348 and 363^371 in P. hybrida FHT are conserved and separated by a highly vari-
able sequence (residues 349^362), as indicated in the bottom line. For comparison, the respective C-terminal portions of FNS I from
Petroselinum crispum (Pet-c) and of FLS from C. unshiu (Cit-u) are also shown.
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BAS 1000 Bio-Imaging Analyzer with TINA software (Raytest, Strau-
benhardt, Germany).
3. Results and discussion
3.1. FHT deletion mutants
Previous attempts to purify Petunia FHT, encoded in a
polypeptide of 371 amino acids, from plant tissues [9] or after
expression in E. coli [8] revealed that the enzyme activity was
almost completely lost upon deletion of a 3.8 kDa C-terminal
peptide, corresponding to 33^34 amino acid residues [10]. The
relevance of the C-terminal portion of ¢ve to 20 amino acids
for enzyme activity had also been proposed for some other 2-
ODDs and non-heme iron(II) enzymes [15,23^27], although
this does not apply to all 2-ODDs. Thus a systematic ap-
proach appears necessary in each instance to correlate the
extent of deletions with enzyme activity. Petunia FHT ap-
peared to be particularly suited for the deletion experiments,
because this hydroxylase has been expressed routinely in E.
coli at high speci¢c activity and puri¢ed to homogeneity
[10,32]. Furthermore, FHT shows narrow speci¢city as com-
pared, for example, to FLS [38^40]. A cluster alignment of 27
di¡erent FHT polypeptides revealed two strictly conserved
motifs in the C-terminal region, corresponding to residues
320^348 and 363^371 in Petunia FHT, separated by an inter-
vening sequence of variable length and composition (Fig. 3).
Conceivably, this region contributes to the overall stability
and architecture of the enzyme, but the conserved motif far
downstream (ILA) might also qualify as a hydrophobic lid
proposed to close the active site of 2-ODDs during catalysis
[23,24]. In some FHTs, this motif is modi¢ed by a conserva-
tive exchange to IFA, whereas the mutation to NLA (Fig. 3)
as in the recently cloned FNS I from parsley [40] a¡ects the
hydrophilicity. Four truncated FHT cDNAs were generated
for the expression of hydroxylase deletion mutants lacking ¢ve
(CT1), 11 (CT2), 24 (CT3) or 29 (CT4) amino acid residues
from the C-terminus (Fig. 3). These deletions were chosen to
remove the conserved downstream tripeptide only (CT1), the
tripeptide including part or all of the intervening sequence
(CT2, CT3) and additional amino acids from the second con-
served motif (CT4).
The wild-type and mutant genes were expressed in isopropyl
thiogalactose (IPTG)-induced E. coli cells and bacterial crude
extracts were examined after SDS^PAGE separation by pro-
tein staining and Western blotting (data not shown). These
experiments revealed that the wild-type and mutant FHTs
were expressed at equivalent levels. The individual enzymes
were puri¢ed to homogeneity from the extracts by size exclu-
sion and anion exchange chromatographies at pH 7.5 as de-
scribed elsewhere [10]. The chromatographic elution pro¢les
of the mutants CT1^CT4 matched that of the wild-type FHT,
strongly suggesting that the mutant enzymes had not under-
gone major conformational changes. The homogeneous FHTs
were compared by SDS^PAGE and their identity was corro-
borated by immunoblotting (Fig. 4A).
3.2. Activities of FHT deletion mutants
The catalytic activities of the FHT mutants CT1^CT4 were
assayed using (2S)-[4a,6,8-14C]naringenin as a substrate and
compared to the activity of wild-type FHT. The increase in
the size of the deletions correlated with a decrease in speci¢c
activity, underlining that the C-terminal domain of Petunia
FHT is essential for full enzymatic activity. Nevertheless,
the amino acids beyond residue 346 appear to be of marginal
importance, because the speci¢c activity of mutant CT1 still
reached 44% and dropped to only 27.5% of the wild-type
FHT in mutant CT3 (Table 2). Most notably, the far down-
stream tripeptide ILA (residues 369^371) is not essentially
required for catalysis, despite the fact that it is strictly con-
served in FHTs. This result is reminiscent of the conclusion
reached recently for DAOCS/DACS from A. chrysogenum,
since the C-terminal deletion of 20 amino acids did not a¡ect
Fig. 4. Western blotting of homogeneous P. hybrida wild-type FHT (WT) and of FHT mutants CT1^CT4 (A; approximately 2 Wg protein/
lane) or of the recombinant FHT/FLS chimera in crude bacterial extract (B; 10 Wg protein). The enzymes were subjected to SDS^PAGE on a
12.5% polyacrylamide gel, blotted to polyvinylidene di£uoride membranes and probed with polyclonal rabbit antibodies raised against Petunia
FHT [42]. Molecular size markers are indicated in the left margin.
Table 2
Activities of recombinantly expressed wild-type FHT and FHT mutants
Enzyme Speci¢c activity (mkat/kg) Relative speci¢c activity (%)
Wild-type 31.8 100
Mutant CT1 14.0 44
Mutant CT2 10 31.5
Mutant CT3 8.7 27.4
Mutant CT4 0.12 0.4
Mutant FHT/FLS chimera 0.09 0.3
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penicillin ring expansion [26]. Further deletions of the FHT C-
terminus as in mutant CT4 (29 residues) drastically dimin-
ished the FHT activity (Table 2), and, in retrospect, these
results explain the activity losses which occurred in crude
plant and bacterial extracts by proteolysis of the C-terminal
33/34 amino acids [10].
A set of potential substrates, including 4-chromanone, var-
ious £avanols (dihydrokaempferol, dihydroquercetin, dihy-
dromyricitin), £avanones (£avanone, 4P-hydroxy£avanone, 7-
hydroxy£avanone, naringenin, eriodictyol and pinocembrin)
was used to examine the substrate selectivities of the wild-
type and mutant enzymes. As reported for the wild-type
FHT, the mutants CT1^CT4 catalyzed the 3L-hydroxylation
of £avanones only (Table 3) and did not develop FLS or any
other activity under the conditions employed.
3.3. FHT/FLS chimera
Several structural and kinetic investigations documented a
close structural and functional relationship among the £avo-
noid dioxygenases, in particular between Petunia FHT and
FLS from Citrus unshiu [4,38^40]. In contrast to FHT, the
FLS is a bifuntional enzyme that is capable of catalyzing
the FHT reaction in addition to the desaturation of dihydro-
£avonols. Nevertheless, the FHT and FLS di¡er considerably
in length and in their C-terminal polypeptide composition,
irrespective of the overall high degree of similarity (Fig. 3).
The C-terminal di¡erences might be responsible for the di¡er-
ential substrate selectivity, as exempli¢ed very recently in case
of DAOCS from S. clavuligerus [41]. Therefore, a domain
swapping experiment was designed (FHT/FLS-pTZ19R), re-
placing the C-terminal 52 amino acids of FHT by the corre-
sponding peptide region of the FLS from C. unshiu (Fig. 2), in
order to describe more accurately the impact of the FHT C-
terminus. The resulting chimeric cDNA was expressed in E.
coli, and the expression was examined by Western blotting of
the crude bacterial extract. A polyclonal antiserum raised
against Petunia FHT detected a prominent 38 kDa polypep-
tide band (Fig. 4B), whereas polyclonal antibodies generated
to the C. unshiu FLS [4] showed no cross-reaction (data not
shown), suggesting that the FLS C-terminus contains ine⁄-
cient epitopes.
The catalytic activity of the FHT/FLS chimera was ana-
lyzed by using labeled (2S)-naringenin (FHT assay) or
(2R,3R)-dihydrokaempferol (FLS assay) as a substrate
[11,39]. Swapping of the C-terminus greatly diminished the
speci¢c FHT activity to a level of less than 0.5% of the
wild-type enzyme (Table 2), which was nevertheless su⁄cient
for reliable enzyme assays (90 Wkat/kg). However, virtually no
FLS activity was detected with labeled (2R,3R)-dihydro-
kaempferol as substrate. In contrast to the role for substrate
selectivity ascribed to the C-terminus in gibberellin C-20 oxi-
dase [27] or DAOCS from S. clavuligerus [24], these results
clearly demonstrated that the C-terminal portion of FHT ac-
counting for about 13% of the polypeptide does not govern
Table 3
Substrate selectivities of recombinant wild-type and mutant FHTsa
aCrude bacterial extracts were desalted over PD10 columns in sodium acetate bu¡er pH 5.5, and the enzyme activities of the eluates were deter-
mined under standard assays conditions (37‡C, total volume 260 Wl). The £avonoids were isolated from the incubation mixture by repeated ex-
traction with ethyl acetate (100 and 50 Wl) and reversed phase high performance liquid chromatography (HPLC) (Shimadzu, Tokyo, Japan) on
a Nucleodur C18 column (250U4 mm, 5 Wm; Macherey-Nagel, Du«ren, Germany). The elution was monitored by the absorption pro¢le at 280,
308, 320 and 360 nm, and authentic £avonoid samples were employed as references for calibration.
bValues normalized with respect to the activity with naringenin; 100 corresponds to the individual speci¢c activities listed in Table 2. The data
are the average from triplicate incubations, with variations 6 15% between the assays.
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the selectivity of this enzyme. Further investigations on the
structure^activity relationship of 2-ODDs, including FHT, are
necessary to assess the impact of single amino acid substitu-
tions in the C-terminal region for substrate selectivity.
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